. 2009 Jun;25(6):345–354. doi: 10.1016/s0828-282x(09)70088-1

TABLE 1.

Baseline characteristics of Canadian participants in the international REduction of Atherothrombosis for Continued Health (REACH) Registry

	Total (n=1976)	*Asymptomatic^ (n=345)**	Symptomatic (n=1631)^†	CAD (n=1362)	CVD (394)	PAD (n=148)
Age, years, mean ± SD	68.4±9.9	67.8±9.9	68.6±9.8	68.3±9.8	71.1±9.8	69.3±9.6
Men, %	69.0	56.8	71.5	73.4	65.5	68.9
Diabetes^‡, %	43.7	84.1	35.2	36.2	35.0	46.6
Hypertension^§, %	76.6	88.4	74.1	73.2	82.5	81.8
Hypercholesterolemia, %	84.4	86.4	84.0	86.9	72.8	81.8
Abdominal obesity^¶, %	51.7	68.5	48.2	48.1	48.5	46.9
Overweight/obese (BMI ≥25 kg/m²), %	75.1	80.5	73.9	75.3	69.3	67.3
Smokers, %
Former^**	46.5	32.2	49.6	50.3	46.1	51.7
Current^††	15.7	21.2	14.5	13.9	13.8	31.0
Modified metabolic syndrome^‡‡, %	29.1	51.0	24.5	24.3	25.6	31.1
Impaired fasting glucose^§§, %	22.8	22.3	22.9	24.2	18.0	20.3

Asymptomatic refers to patients enrolled with three or more atherothrombotic risk factors but no overt ischemic event;

^{^†}

Patients may present with polyvascular disease; therefore, this value does not equal the total of coronary artery disease (CAD) + cerebrovascular disease (CVD) + peripheral arterial disease (PAD);

^{^‡}

Patients with type 1 or 2 diabetes currently treated with hypoglycemic agents or a history of diabetes;

^{^§}

Patients with systolic blood pressure ≥150 mmHg despite therapy for ≥3 months or a history of hypertension;

^{^¶}

Men: waist circumference ≥102 cm; women: waist circumference ≥88 cm;

^**

≥5 cigarettes/day (mean) >1 month before enrolment;

^{^††}

≥5 cigarettes/day (mean) within 1 month of enrolment;

^{^‡‡}

Patients with ≥3 of the following: abdominal obesity, triglycerides ≥1.7 mmol/L, blood pressure ≥130/85 mmHg, fasting glucose >6.1 mmol/L;

^{^§§}

Patients with fasting glucose >5.6 mmol/L and <7.0 mmol/L. BMI Body mass index